There is currently no licensed transdermal patch containing tirzepatide. In the UK, Mounjaro (tirzepatide) is authorised as a solution for injection supplied in a pre-filled pen. Current UK product information does not list a patch, cream, gel or other transdermal formulation. This distinction matters because products marketed online as "Mounjaro patches" are not authorised versions of Mounjaro.
Products sold outside the regulated medicines supply chain may contain ingredients that differ from those stated on the packaging and may carry unknown safety risks.
This guide explains why a tirzepatide patch is not currently viable, what is known about products marketed as patches online, how to access genuine Mounjaro safely in the UK, and which licensed needle-free alternatives are available.
Key Things to Know
- Mounjaro is currently authorised in the UK as an injectable medicine supplied in a pre-filled pen. There is no licensed tirzepatide patch listed in the UK product information.
- Tirzepatide is a relatively large peptide molecule, with a molecular weight of approximately 4,800 daltons. Large molecules generally have difficulty crossing intact skin in therapeutically useful amounts, which presents a major challenge for conventional transdermal delivery.
- Products sold online as 'Mounjaro patches' or 'tirzepatide patches' should not be assumed to contain tirzepatide. Some are marketed as supplement patches containing herbal or other ingredients.
- Research is taking place into advanced delivery systems, including microneedle technologies for peptide medicines. However, research-stage delivery systems should not be confused with licensed medicines available for patients.
- Mounjaro remains a prescription-only medicine in the UK, available only through a clinical assessment with a UK-registered prescriber and dispensing via a GPhC-registered pharmacy.
Do Mounjaro Patches Exist?
There is currently no licensed patch, cream, gel, spray or sublingual formulation of Mounjaro (tirzepatide) in the UK. The current UK product information describes Mounjaro as a solution for subcutaneous injection supplied in a pre-filled pen.
Why a Tirzepatide Patch Is Not Currently Available
One of the main challenges is molecular size. The outer layer of the skin provides a strong barrier to the passage of many medicines, particularly larger molecules.
Tirzepatide is a peptide with a molecular weight of approximately 4,800 daltons, making conventional passive delivery through intact skin particularly challenging. Some medicines can be delivered through conventional transdermal patches because their chemical and physical properties allow them to cross the skin. Nicotine and some hormone medicines are examples. Peptide medicines such as tirzepatide present a substantially greater delivery challenge.
Molecular Weight and Active Ingredient Tirzepatide: Why Some Drugs Work as Patches and Others Do not
| Drug | Molecular weight | Works as a simple patch? |
|---|---|---|
| Nicotine | ~162 Da | Yes |
| Estradiol | ~272 Da | Yes |
| Fentanyl | ~336 Da | Yes |
| Tirzepatide | ~4,810 Da | Not suitable for conventional passive transdermal delivery |
Researchers are investigating advanced delivery technologies, including microneedle systems that can bypass some of the barriers presented by intact skin. These approaches are still part of pharmaceutical research and development and should not be confused with an authorised Mounjaro patch. Any future formulation would need appropriate clinical development and regulatory assessment before it could be supplied as a medicine.
What Are the "Mounjaro" Weight Loss Patches Sold Online?
Products marketed online as "Mounjaro patches", "tirzepatide patches" or "GLP-1 patches" are not authorised formulations of Mounjaro. The composition of products sold online under these descriptions can vary.
Unless a product has been appropriately authorised and supplied through the regulated medicines system, you should not assume that it contains tirzepatide or another GLP-1 medicine simply because the packaging or advertising says so.
Some products marketed in this way may contain dietary or plant-derived ingredients rather than tirzepatide. However, the ingredients and quality of individual products can vary, so consumers should check the product carefully and avoid assuming that a product marketed as a "Mounjaro patch" contains the licensed medicine.
There is no established clinical evidence that products marketed as unlicensed 'Mounjaro patches' provide the therapeutic effects of licensed tirzepatide treatment.
Is It Safe to Buy a Mounjaro Patch?
Unlicensed products marketed as "Mounjaro patches" may carry unknown risks because their ingredients, strength, manufacturing quality and safety may not have undergone the regulatory assessment required for licensed medicines in the UK. Any product claiming to deliver tirzepatide through the skin should not be assumed to contain a known or reliable dose. A product containing tirzepatide would need the appropriate marketing authorisation and regulated supply arrangements to be lawfully marketed as a medicine in the UK.
Spending money on these products means paying for something that has not been established as a safe and effective alternative to licensed weight-management medicines, and the quality and safety of the product may be uncertain.
How Prescription Medicines Are Supplied Safely in the UK
Prescription-only medicines should only be supplied following an appropriate consultation with a qualified healthcare professional. The assessment should consider relevant medical history, current medicines, contraindications, interactions and other factors that may affect whether treatment is appropriate.
The MHRA states that GLP-1 medicines are prescription-only and that private treatment requires a consultation with a healthcare professional before a prescription can be issued.
For its UK-authorised weight-management indication, tirzepatide can be used in adults with a BMI of 30 kg/m² or above, or a BMI of at least 27 kg/m² but below 30 kg/m² where there is at least one weight-related health condition. If a prescriber considers a prescription medicine appropriate, they can issue a prescription in accordance with the applicable UK requirements. The medicine must then be supplied through an appropriate, regulated medicines supply route.
This assessment is intended to establish whether the medicine is safe and suitable for the individual. For weight management, tirzepatide is used alongside a reduced-calorie diet and increased physical activity. The duration of treatment should be determined with a healthcare professional according to the individual's circumstances and response to treatment.
Needle-Free Alternatives to Mounjaro
Some licensed medicines are available in oral formulations, depending on the condition being treated and the individual's circumstances. They do not contain tirzepatide simply because they are taken by mouth, and their approved uses and suitability differ between medicines.
These work differently to a patch: they are swallowed, absorbed through the digestive system rather than the skin, and have their own separate licensing and evidence base. If needle-free treatment matters to you, it is worth raising this directly during your consultation so your prescriber can talk you through what's actually licensed and suitable.
Weight-management treatment is generally used alongside lifestyle measures, including a balanced diet and regular physical activity.
How to Check Whether a Medicine Is Genuine
Prescription-only medicines should be obtained only through an appropriate regulated supply route and following a consultation where required.
The MHRA advises patients not to buy GLP-1 medicines without a prescription and recommends obtaining medicines from registered UK pharmacies or legitimate retailers. Clinical trials have demonstrated that tirzepatide can produce substantial reductions in body weight in adults who meet the relevant study criteria.
The UK product information confirms that weight-management treatment is used alongside a reduced-calorie diet and increased physical activity.
Medical Disclaimer and Side Effects
This article is for general information only and does not constitute medical advice. Mounjaro is a prescription-only medicine and is not suitable for everyone. Seek treatment through a licensed UK prescriber and GPhC-registered pharmacy. Products claiming to contain or deliver prescription medicines through unlicensed patches, creams or supplements should not be assumed to have the same quality, safety or effectiveness as authorised medicines. If you are considering an unlicensed product, speak to a pharmacist or other healthcare professional before using it.
